Abstract:OBJECTIVE:To evaluate the efficacy and safety of Yiqing Shuangjie Capsule and Tablet in treating acute upper respiratory tract infection with wind-warm syndrome.METHODS:The multiple center, double-blinded, double-dummy and randomized controlled method was conducted. Three hundred and sixty patients were randomly divided into the treatment group A (n=120, treated with Yiqing Shuangjie Capsule and Chaihuang analogues), treatment group B (n=120, treated with Yiqing Shuangjie Tablet and Chaihuang analogues) and the control group (n=120, treated with Chaihuang Tablet and Yiqing Shuangjie Capsule analogues). Every drug was administered 3 pills each time. Patients in the three groups were all treated for 5 days and three times daily. The accumulated scores of syndrome, clinical symptoms, adverse effect and body temperature were recorded before and after the treatment. The safety indexes, such as routine tests of blood, urine and stool, hepatic and renal function tests and electrocardiogram (ECG) were taken before and after the treatment.RESULTS:Three cases were excluded and eighteen cases lost to follow-up. There were 343 patients who entered to the intention-to-treat (ITT) analysis and 339 patients fitted in the per-protocol population set (PPS) analysis. After treatment, the therapeutic effects of respiratory tract infection were calculated by ITT and PPS analysis respectively. The rates of total obvious effect were 84.96% and 87.27% respectively in the treatment group A, and the total response rates were 96.46% and 97.27% respectively. The rates of total obvious effect were 85.47% and 86.20% respectively in the treatment group B, and the total response rates were 97.45% and 97.41% respectively. In the control group, the rates of total obvious effect both were 72.57%, and the total response rates both were 99.12%. There was significant difference among the three groups (P<0.05). The effects of traditional Chinese medicine syndrome were also detected by ITT and PPS analysis respectively. In the treatment group A, the total obvious effect rates were 84.07% and 85.46% respectively, and the total response rates were 96.46% and 97.27% respectively. In the treatment group B, the rates of total obvious effect were 88.89% and 89.65% respectively, and the total response rates were 97.44% and 97.41% respectively. In the control group, the rates of total obvious effect both were 72.57%, and total response rates both were 99.12%. There was also statistical significant difference among the three groups (P<0.05). ITT and PPS analysis had the same results. No adverse effect was found in the trial.CONCLUSION:Yiqing Shuangjie Capsule and Tablet are effective and safe in treating acute upper respiratory tract infection of wind heat syndrome without obvious adverse effect.

A Controlled Study on Ibuprofen Pseudoephedrine Hydrochloride and Chlorpheniramine Maleate Tablets and Paracetamol Pseudoephedrine Hydrochloride and Chlorphenamine Maleate Tablets in the Treatment of Upper Respiratory Tract Infection

A phase Ⅲ clinical trial of ibuprofen, pseudoephedrine hydrochloride and chlorphenamine maleate tablets in treatment of adult cold

Efficacy and Safety of Loratadine Paracetamol and Pseudoephedrine Sustained Release Tablets in the Treatment of Common Cold and Influenza

New Strategy for Cough Treatment-Comparison Effect and Safety of Cofetol Cough Syrup with Dextromethorphan Hydrobromide, Chorpheniramine Mateate and Pseudoe Phedrine Hydiochloride Solution in the Treatment of Acute Cough

A Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Lvpuweima Sustained-Release Tablet in the Treatment of Common Cold

A Multiple Center, Randomized, Controlled, Double-Blinded and Double-Dummy Trial of Yiqing Shuangjie Capsule and Tablet in Treating Acute Upper Respiratory Tract Infection with the Syndrome of Heat Attacking the Lung and Weifen

Efficacy and Safety of Dextromethorphan-Chlorpheniramine-pseudoephedrine Solution in Treating Cough Caused by Acute Upper Respiratory Tract Infections in 133 Patients

Clinical study on the efficacy and safety of Dextromethorphan Hydrochloride, Chlorphenamine Malente, and Ammonium Chloride Syrup on eliminating or relieving the symptoms of acute upper respiratory infection in children

Efficacy and Safety of Guaifenesin-Pseudoephedrine Hydrochloride-Codeine Phosphate Oral Solution

Efficacy and Safety of Cetirizine-Pseudoephedrine Sustained-Release Tablets in the Treatment of Seasonal and Perennial Allergic Rhinitis

Clinical Study of Inhaled Ambroxol in the Adjunctive Treatment of Lower Respiratory Tract Infection Induced by Pseudomonas Aeruginosa

The effectiveness and safety of Chaiqin Qingning Capsule in upper respiratory tract infections with fever: A prospective, double-blinded, randomized, multicenter controlled trial

EFFICACY AND SAFETY FOR THE COMBINATION OF PARACETAMOL, PHENYLEPHRINE AND CHLORPHENIRAMINE MALEATE IN INDIAN PAEDIATRIC PATIENTS OF COMMON COLD AND ALLERGIC RHINITIS- POST-MARKETING SURVEILLANCE STUDY

A Double-Blind, Randomized Controlled Trial of Chaige Qingre Granule in Treating Acute Upper Respiratory Tract Infection of Wind Heat Syndrome

Application of lianhua qingwen capsules in fever clinic

Administration of tylenol cold tablets in 58 adults with upper respiratory tract infection accompanied by acute abdominal pain

A randomized controlled study of peramivir, oseltamivir and placebo in patients with mild influenza

Bioequivalence of Ibuprofen,pseudoephedrine and Chlorphenamine for Tablet and Suspension in Healthy Volunteers

A Randomly Controlled Clinical Trial of Aspirin-vitamin C Dispersible Tablets in Patients with Acute Upper Respiratory Tract Infection

Clinical study on Bishushi Tablets combined with desloratadine citrate disodium in treatment of allergic rhinitis

Effect and Safety of Pseudoephedrine-Dextromethorphan Drops